Primary and metastatic brain tumors, post-surgery or radiation therapy.
Hodgkin lymphoma that has advanced after initial chemotherapy; used in combination with other agents.
We are committed to maintaining a reliable and consistent supply of CeeNU® so that patients and healthcare providers have access to this essential therapy when it matters most.
CeeNU® is a registered trademark of Septa Pharma Inc. | © Copyright 2026 | All Right Reserved